EMA Authorised: Votubia (everolimus) — Novartis Europharm Limited

View source ↗

Summary

The European Medicines Agency authorised Votubia (everolimus) for use in tuberous sclerosis, with Novartis Europharm Limited as the marketing authorization hold…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberous Sclerosis

Drugs mentioned

• Votubia (everolimus)

Snippet

Status: Authorised. Therapeutic area: Tuberous Sclerosis. MAH: Novartis Europharm Limited. Decision date: 20/11/2025